In the cell model of lung cancer treated with cisplatin, miR-7 decoupled the interaction between Smarcd1 and P53 and then reduced P53-dependent downstream apoptosis cascades, thus promoting tumor chemoresistance [10]. This evidence concerns the gene TP53 and lung cancer.